GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹419 Cr | ₹1,066 Cr | ₹921 Cr | ₹1,218 Cr | ₹1,091 Cr |
What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?
Year | Capital Work in Progress |
---|---|
Mar2024 | ₹419 Cr |
Mar2023 | ₹1,066 Cr |
Mar2022 | ₹921 Cr |
Mar2021 | ₹1,218 Cr |
Mar2020 | ₹1,091 Cr |
How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2024 | ₹419 Cr | -60.66 | |
Mar2023 | ₹1,066 Cr | 15.71 | |
Mar2022 | ₹921 Cr | -24.36 | |
Mar2021 | ₹1,218 Cr | 11.66 | |
Mar2020 | ₹1,091 Cr | - |
Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹57,680.3 Cr | 1.3% | -7.2% | 37.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 1.3% |
-7.2% |
37.5% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses